Production and evaluation of reagents for detection of Histoplasma capsulatum antigenuria by enzyme immunoassay

Clinical and Vaccine Immunology

Volumn 14, Issue 6, 2007, Pages 700-709

  Lindsley, Mark D ^a,b   Holland, Heather L ^a,c   Bragg, Sandra L ^a   Hurst, Steven F ^a   Wannemuehler, Kathleen A ^a   Morrison, Christine J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Mailstop G 11 ^*  (United States)

^c Centers for Disease Control and Prevention   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; FUNGUS ANTIGEN; HISTOPLASMA CAPSULATUM POLYSACCHARIDE ANTIGEN; RABBIT ANTISERUM; REAGENT; UNCLASSIFIED DRUG; WHOLE KILLED YEAST PHASE CELL ANTIGEN;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ANTIGENURIA; ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; EVALUATION; FEMALE; FUNGAL DETECTION; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; IMMUNIZATION; MICTURITION DISORDER; NONHUMAN; PRIORITY JOURNAL; PRODUCTIVITY; RABBIT; YEAST CELL;

ANIMALS; ANTIBODIES, FUNGAL; ANTIGENS, FUNGAL; FEMALE; HISTOPLASMA; HISTOPLASMOSIS; HUMANS; IMMUNOENZYME TECHNIQUES; INJECTIONS, INTRAVENOUS; RABBITS; SENSITIVITY AND SPECIFICITY;

EID: 34547135929     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.00083-07     Document Type: Article

References (48)

1. Ajello, L. 1964. Relationship of Histoplasma capsulatum to avian habitats. Public Health Rep. 79:266-270.
2. Azuma, I., F. Kanetsuna, Y. Tanaka, Y. Yamamura, and L. M. Carbonell. 1974. Chemical and immunological properties of galactomannans obtained from Histoplasma duboisii, Histoplasma capsulatum, Paracoccidioides brasiliensis and Blastomyces dermatitidis. Mycopathol. Mycol. Appl. 54:111-125.
3. Baumgardner, D. J., E. M. Knavel, D. Steber, and G. R. Swain. 2006. Geographic distribution of human blastomycosis cases in Milwaukee, Wisconsin, USA: association with urban watersheds. Mycopathologia 161:275-282.
4. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
5. Broderson, J. R. 1989. A retrospective review of lesions associated with the use of Freund's adjuvant. Lab. Anim. Sci. 39:400-405.
6. Cahn, P., W. H. Belloso, J. Murillo, and G. Prada-Trujillo. 2000. AIDS in Latin America. Infect. Dis. Clin. N. Am. 14:185-209.
7. Chamany, S., S. A. Mirza, J. W. Fleming, J. F. Howell, S. W. Lenhart, V. D. Mortimer, M. A. Phelan, M. D. Lindsley, N. J. Iqbal, L. J. Wheat, M. E. Brandt, D. W. Warnock, and R. A. Hajjeh. 2004. A large histoplasmosis outbreak among high school students in Indiana, 2001. Pediatr. Infect. Dis. J. 23:909-914.
8. Chapman, S. W., R. W. Bradsher, Jr., G. D. Campbell, Jr., P. G. Pappas, and C. A. Kauffman. 2000. Practice guidelines for the management of patients with blastomycosis. Clin. Infect. Dis. 30:679-683.
9. Chu, J. H., C. Fendtner, K. Heydon, T. J. Walsh, and T. E. Zaoutis. 2006. Hospitalizations for endemic mycoses: a population-based national study. Clin. Infect. Dis. 42:822-825.
10. Das, S., M. D. Lindsley, and C. J. Morrison. 2005. Abstr. 105th Gen. Meet. Am. Soc. Microbiol., abstr. F-016.
11. de Francesco Daher, E., F. A. de Sousa Barros, G. B. da Silva, Jr., C. F. Takeda, R. M. Mota, M. T. Ferreira, J. C. Martins, S. A. Oliveira, and O. A. Gutierrez-Adrianzen. 2006. Risk factors for death in acquired immunodeficiency syndrome-associated disseminated histoplasmosis. Am. J. Trop. Med. Hyg. 74:600-603.
12. Domer, J. E. 1971. Monosaccharide and chitin content of cell walls of Histoplasma capsulatum and Blastomyces dermatitidis. J. Bacteriol. 107:870-877.
13. Dubois, M., H. Gillis, J. Hamilton, A. Rebers, and R. Smith. 1956. Colorimetric method for the determination of sugars and related substances. Anal. Biochem. 28:250-256.
14. Durkin, M. M., P. A. Connolly, and L. J. Wheat. 1997. Comparison of radioimmunoassay and enzyme-linked immunoassay methods for detection of Histoplasma capsulatum var. capsulatum antigen. J. Clin. Microbiol. 35:2252-2255.
15. Garringer, T. O., L. J. Wheat, and E. J. Brizendine. 2000. Comparison of an established antibody sandwich method with an inhibition method of Histoplasma capsulatum antigen detection. J. Clin. Microbiol. 38:2909-2913.
16. Goldman, M., R. Zackin, C. J. Fichtenbaum, D. J. Skiest, S. L. Koletar, R. Hafner, L. J. Wheat, P. M. Nyangweso, C. T. Yiannoutsos, C. T. Schnizlein-Bick, S. Owens, J. A. Aberg, and AIDS Clinical Trials Group A5038 Study Group. 2004. Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy. Clin. Infect. Dis. 38:1485-1489.
17. Hage, C. A., T. E. Davis, L. Egan, M. Parker, D. Fuller, A. M. Lemonte, M. Durkin, P. Connelly, L. J. Wheat, D. Blue-Hnidy, and K. S. Knox. 2007. Diagnosis of pulmonary histoplasmosis and blastomycosis by detection of antigen in bronchoalveolar lavage fluid using an improved second-generation enzyme-linked immunoassay. Respir. Med. 101:43-47.
18. Hajjeh, R. A., P. G. Pappas, H. Henderson, D. Lancaster, D. M. Bamberger, K. J. Skahan, M. A. Phelan, G. Cloud, M. Holloway, C. A. Kauffman, L. J. Wheat, and National Institute of Allergy and Infectious Diseases Mycoses Study Group. 2001. Multicenter case-control study of risk factors for histoplasmosis in human immunodeficiency virus-infected persons. Clin. Infect. Dis. 32:1215-1220.
19. Halliday, L. C., J. E. Artwohl, R. M. Bunte, V. Ramakrishnan, and B. T. Bennett. 2004. Effects of Freund's complete adjuvant on the physiology, histology, and activity of New Zealand white rabbits. Contemp. Top. Lab. Anim. Sci. 43:8-13.
20. Hebert, G. A. 1976. Improved salt fractionation of animal serums for immunofluorescence studies. J. Dent. Res. 55:A33-37.
21. Kauffman, C. A. 2001. Pulmonary histoplasmosis. Curr. Infect. Dis. Rep. 3:279-285.
22. Lindsley, M. D., D. W. Warnock, and C. J. Morrison. 2006. Serological and molecular diagnosis of fungal infections, p. 569-605. In B. Derrick, R. G. Hamilton, and J. D. Folds (ed.), Manual of molecular and clinical laboratory immunology, 7th ed. ASM Press, Washington, DC.
23. Lyon, G. M., A. V. Bravo, A. Espino, M. D. Lindsley, R. E. Gutierrez, I. Rodriguez, A. Corella, F. Carrillo, M. M. McNeil, D. W. Warnock, and R. A. Hajjeh. 2004. Histoplasmosis associated with exploring a bat-inhabited cave in Costa Rica, 1998-1999. Am. J. Trop. Med. Hyg. 70:438-442.
24. Pine, L. 1957. Studies of the growth of Histoplasma capsulatum. III. Effects of thiamin and other vitamins on the growth of the yeast and mycelial phases of Histoplasma capsulatum. J. Bacteriol. 74:239-245.
25. Reiss, E., L. Kaufman, J. A. Kovacs, and M. D. Lindsley. 2002. Clinical immunomycology, p. 559-583. In N. R. Rose, R. G. Hamilton, and B. Detrick (ed.), Manual of clinical laboratory immunology, 6th ed. ASM Press, Washington, DC.
26. Reiss, E., J. B. Knowles, S. L. Bragg, and L. Kaufman. 1986. Monoclonal antibodies against the M-protein and carbohydrate antigens of histoplasmin characterized by the enzyme-linked immunoelectrotransfer blot method. Infect. Immun. 53:540-546.
27. Reiss, E., W. O. Mitchell, S. H. Stone, and H. F. Hasenclever. 1974. Cellular immune activity of a galactomannan-protein complex from mycelia of Histoplasma capsulatum. Infect. Immun. 10:802-809.
28. Sathapatayavongs, B., B. E. Batteiger, J. Wheat, T. G. Slama, and J. L. Wass. 1983. Clinical and laboratory features of disseminated histoplasmosis during two large urban outbreaks. Medicine (Baltimore) 62:263-270.
29. Scbeel, C., L. Benjamin, J. Morgan, S. Hurst, B. Samayoa, M. Lindsley, B. Arthington-Skaggs, and E. Arathoon. 2006. Abstr. 16th Congr. Int. Soc. Hum. Anim. Mycol., abstr. P-0422.
30. Stills, H. F., Jr. 2005. Adjuvants and antibody production: dispelling the myths associated with Freund's complete and other adjuvants. ILAR J. 46:280-293.
31. Tewari, R. P., D. K. Shanna, and A. Mathur. 1978. Significance of thymus-derived lymphocytes in immunity elicited by immunization with ribosomes or live yeast cells of Histoplasma capsulatum. J. Infect. Dis. 138:605-613.
32. Tobon, A. M., C. A. Agudelo, D. S. Rosero, J. E. Ochoa, C. De Bedout, A. Zuluaga, M. Arango, L. E. Cano, J. Sampedro, and A. Restrepo. 2005. Disseminated histoplasmosis: a comparative study between patients with acquired immunodeficiency syndrome and non-human immunodeficiency virus-infected individuals. Am. J. Trop. Med. Hyg. 73:576-582.
33. Wheat, J. 1996. Histoplasmosis in the acquired immunodeficiency syndrome. Curr. Top. Med. Mycol. 7:7-18.
34. Wheat, J. 1997. Histoplasmosis. Experience during outbreaks in Indianapolis and review of the literature. Medicine (Baltimore) 76:339-354.
35. Wheat, J., M. L. French, S. Kamel, and R. P. Tewari. 1986. Evaluation of cross-reactions in Histoplasma capsulatum serologic tests. J. Clin. Microbiol. 23:493-499.
36. Wheat, J., G. Sarosi, D. McKinsey. R. Hamill, R. Bradsher, P. Johnson, J. Loyd, and C. Kauffman. 2000. Practice guidelines for the management of patients with histoplasmosis. Clin. Infect. Dis. 30:688-695.
37. Wheat, J., H. Wheat, P. Connolly, M. Kleiman, K. Supparatpinyo, K. Nelson, R. Bradsber, and A. Restrepo. 1997. Cross-reactivity in Histoplasma capsulatum variety capsulatum antigen assays of urine samples from patients with endemic mycoses. Clin. Infect. Dis. 24:1169-1171.
38. Wheat, L. J. 2003. Current diagnosis of histoplasmosis. Trends Microbiol. 11:488-494.
39. Wheat, L. J., P. Connolly, M. Durkin, B. K. Book, and M. D. Pescovitz. 2006. Elimination of false-positive Histoplasma antigenemia caused by human anti-rabbit antibodies in the second-generation Histoplasma antigen assay. Transpl. Infect. Dis. 8:219-221.
40. Wheat, L. J., P. Connolly, M. Durkin, B. K. Book, A. J. Tector, J. Fridell, and M. D. Pescovitz. 2004. False-positive Histoplasma antigenemia caused by antithymocyte globulin antibodies. Transpl. Infect. Dis. 6:23-27.
41. Wheat, L. J., P. Connolly-Stringfield, R. B. Kohler, P. T. Frame, and M. R. Gupta. 1989. Histoplasma capsulatum polysaccharide antigen detection in diagnosis and management of disseminated histoplasmosis in patients with acquired immunodeficiency syndrome. Am. J. Med. 87:396-400.
42. Wheat, L. J., P. A. Connolly-Stringfield, R. L. Baker, M. F. Curfman, M. E. Eads, K. S. Israel, S. A. Norris, D. H. Webb, and M. L. Zeckel. 1990. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore) 69:361-374.
43. Wheat, L. J., T. Garringer, E. Brizendine, and P. Connolly. 2002. Diagnosis of histoplasmosis by antigen detection based upon experience at the histoplasmosis reference laboratory. Diagn. Microbiol. Infect. Dis. 43:29-37.
44. Wheat, L. J., R. B. Kohler, and R. P. Tewari. 1986. Diagnosis of disseminated histoplasmosis by detection of Histoplasma capsulatum antigen in serum and urine specimens. N. Engl. J. Med. 314:83-88.
45. Wheat, L. J., E. J. Hackett, and P. A. Connolly. 2006. Abstr. 46th Intersci. Conf. Antimicrob. Agents Chemother., abstr. M-1611.
46. Williams, B., M. Fojtasek, P. Connolly-Stringfield, and J. Wheat. 1994. Diagnosis of histoplasmosis by antigen detection during an outbreak in Indianapolis, Ind. Arch. Pathol. Lab. Med. 118:1205-1208.
47. Zancope-Oliveira, R. M., S. L. Bragg, S. F. Hurst, J. M. Peralta, and E. Reiss. 1993. Evaluation of cation exchange chromatography for the isolation of M glycoprotein from histoplasmin. J. Med. Vet. Mycol. 31:29-41.
48. Zancope-Oliveira, R. M., S. L. Bragg, E. Reiss, and J. M. Peralta. 1994. Immunochemical analysis of the H and M glycoproteins from Histoplasma capsulatum. Clin. Diagn. Lab. Immunol. 1:563-568.